• Artesunate: Applied Workflows for Advanced Cancer Research

  2026-07-08

  Artesunate, a potent artemisinin derivative from APExBIO, empowers researchers to dissect complex cell death pathways in small cell lung and esophageal squamous cell carcinoma models. This guide details optimized protocols, advanced troubleshooting strategies, and actionable insights inspired by cutting-edge in vitro evaluation methodology.

• IWP-2: Wnt Production Inhibitor for Advanced Cancer Research

  2026-07-08

  IWP-2, a selective Wnt production inhibitor from APExBIO, empowers researchers to dissect Wnt/β-catenin signaling with precision in cancer and neurodevelopmental assays. Discover how its robust potency and workflow versatility enable reproducible apoptosis assays, migration studies, and translational investigations.

• Indometacin Sodium Promotes Remyelination via β-Catenin Regu

  2026-07-07

  Preisner et al. (2015) reveal that indometacin, a non-steroidal anti-inflammatory drug, enhances endogenous remyelination by modulating the Wnt/β-catenin pathway and promoting oligodendrocyte differentiation. These findings suggest a potential adjunctive strategy for multiple sclerosis therapies targeting remyelination.

• Morphological Profiling Reveals HSPB7 Rescue in Titin Cardio

  2026-07-07

  This study introduces CARDIO, a high-content imaging platform for profiling morphological and functional changes in human stem cell-derived cardiomyocytes. By applying this approach to titin-deficient models of dilated cardiomyopathy, the authors identified HSPB7 loss as a genetic perturbation that unexpectedly restores contractile function, offering new insight into heart failure mechanisms.

• MnTBAP Chloride: Advancing Mitochondrial Redox Stress Models

  2026-07-06

  MnTBAP Chloride empowers oxidative stress and neuroinflammation research with robust, cell-permeable SOD mimetic activity, enabling reproducible protection in both cell culture and animal models. Its validated role in modulating mitochondrial dysfunction and inflammation underpins its value for dissecting complex stress-linked pathologies. Researchers benefit from standardized workflows, practical troubleshooting, and data-backed comparative advantages that set MnTBAP Chloride apart.

• Small Molecule Enhancement of Pancreatic Ductal Organoid Gen

  2026-07-06

  The referenced study demonstrates a robust protocol using a small molecule cocktail to significantly boost the efficiency and stability of pancreatic ductal organoid (PDO) formation from Sox9-positive cells. This advancement provides a reproducible, physiologically relevant model for studying pancreatic diseases and supports high-throughput drug screening.

• Grazoprevir/Elbasvir for HCV: Innovations in Replication Inh

  2026-07-05

  The reference study details the clinical and mechanistic advances of the grazoprevir/elbasvir fixed-dose combination for hepatitis C, demonstrating high sustained virologic response rates across genotypes and patient populations. This evidence highlights the shift toward highly potent, well-tolerated oral regimens that address prior limitations in HCV therapy, with implications for research and clinical translation.

• ICG001: A Selective Wnt/β-Catenin Pathway Inhibitor in Trans

  2026-07-04

  ICG001 empowers researchers to dissect the CBP/β-catenin axis in cancer and fibrosis with precision, enabling robust, reproducible modulation of Wnt signaling. Its selectivity and well-validated protocols unlock new dimensions in disease modeling and therapeutic development.

• IRF1-PARP12 Axis Impairs Mitophagy in Osteoarthritis Cartila

  2026-07-03

  This study uncovers how IRF1-driven PARP12 expression promotes cartilage degradation in osteoarthritis by blocking PINK1/Parkin-dependent mitophagy, mediated through ISG15-dependent modification of MFN1/2. The findings clarify a new molecular pathway underlying cartilage catabolism and demonstrate that XAV-939 can attenuate these effects, offering new directions for OA research.

• High-Throughput Blood-Brain Barrier Model for CNS Drug Scree

  2026-07-03

  The referenced study introduces a surrogate in vitro blood-brain barrier (BBB) model using LLC-PK1-MOCK/MDR1 cells, integrating lysosomal trapping correction for accurate permeability prediction. This innovation enables high-throughput, physiologically relevant screening of CNS drug candidates, potentially accelerating early-stage development and reducing reliance on animal models.

• IWR-1-endo: Strategic Use of a Wnt Signaling Inhibitor in Tr

  2026-07-02

  This article delivers a thought-leadership perspective on leveraging IWR-1-endo—a potent Wnt/β-catenin pathway inhibitor—for translational oncology. It fuses mechanistic insights about Axin-scaffolded destruction complex stabilization with actionable guidance for researchers advancing colorectal cancer and regenerative biology studies. By integrating recent advances in single-nucleus RNA-seq and highlighting APExBIO’s product quality, the discussion empowers teams to move beyond standard workflows and anticipate future cross-domain applications.

• IWR-1-endo: Potent Wnt Signaling Inhibitor for Advanced Rese

  2026-07-02

  IWR-1-endo is a nanomolar-potency Wnt signaling inhibitor that blocks β-catenin accumulation by stabilizing Axin destruction complexes. It is validated for disrupting Wnt/β-catenin-driven processes in colorectal cancer and regenerative biology. This article details its mechanism, evidence base, workflow parameters, and limitations for robust experimental design.

• Murine RNase Inhibitor: Robust RNA Protection for Reliable A

  2026-07-01

  Explore how Murine RNase Inhibitor (SKU K1046) addresses persistent challenges in RNA degradation prevention for cell viability and molecular assays. This scenario-driven guide provides quantitative, literature-backed insights to enhance reproducibility, sensitivity, and workflow safety, empowering biomedical researchers with validated best practices.

• Dorsomorphin (Compound C): Advanced AMPK & BMP Assay Solutio

  2026-07-01

  Dorsomorphin (Compound C) enables precise, dual-pathway modulation for dissecting metabolic and differentiation responses in cellular and animal models. This guide delivers actionable workflows, troubleshooting strategies, and new insights from Wnt-mediated bone anabolism studies. Researchers seeking rigorous AMPK inhibition or BMP pathway modulation will find stepwise protocols and integrative analysis approaches here.

• Metabolomics Distinguishes Carbapenemase-Producing Enterobac

  2026-06-30

  This study introduces a metabolomics-driven approach to rapidly identify carbapenemase-producing Enterobacterales (CPE), offering a new diagnostic paradigm beyond conventional culture-based methods. By leveraging LC-MS/MS and machine learning, the research uncovers distinct metabolic signatures linked to resistance phenotypes, with implications for antibiotic stewardship and resistance surveillance.

15768 records 1/1052 page Next 12345 下5页 Last page